Psoriasiform Cutaneous Inflammation
Psoriasiform Cutaneous Inflammation - Related Videos
11:35
Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function
0 Views •
Cited by 16 •
2010
A dual-mode imaging system was developed for non-contact assessment of cutaneous tissue oxygenation and vascular function.
01:38
Inflammation
0 Views •
2019
Overview In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
06:44
Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
0 Views •
Cited by 22 •
2009
A demonstration of the bedside test for cutaneous allodynia and its clinical implications.
11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
0 Views •
Cited by 40 •
2012
Optimization of the experimental hamster model for cutaneous leishmaniasis by intradermal injection of Leishmania promastigotes at the dorsal skin. This approach is useful during inoculation, follow-up, characterization of lesions, application of treatments and obtaining of clinical samples. Locomotion, search for food and water, play and social activities are preserved.
08:50
Fabrication and Characterization of a Conformal Skin-like Electronic System for Quantitative, Cutaneous Wound Management
0 Views •
Cited by 7 •
2015
This article presents methods to fabricate and characterize a conformal, skin-like electronic system and protocols for the use in clinical applications, particularly on cutaneous wound management.
FAQs
Activated dendritic cells and T cells contribute inflammatory mediators that reinforce communication between immune cells and the epidermis. Interleukin-17 and tumor necrosis factor are especially important because they stimulate keratinocytes to produce chemokines. These signals promote further leukocyte recruitment, creating a self-reinforcing inflammatory environment that can intensify tissue injury and epidermal abnormalities.
Keratinocytes respond to immune-derived cytokines by producing additional chemokines, which help attract leukocytes into the skin. This response links cytokine signaling to the cellular infiltrate observed in psoriasiform cutaneous inflammation. It also means that altered epidermal differentiation and immune recruitment develop together, making keratinocyte signaling relevant to studies of barrier disruption and inflammatory amplification.
Interleukin-17 and tumor necrosis factor act as inflammatory mediators that connect activated immune cells with epidermal responses. Their signaling stimulates keratinocytes to release chemokines, thereby supporting leukocyte recruitment and sustaining local inflammation. Examining this pathway helps researchers relate immune activation to epidermal thickening, altered keratinocyte differentiation, and immune-mediated tissue injury.
The pattern reflects interaction between innate and adaptive immune pathways rather than activity from one immune compartment alone. Dendritic-cell activation contributes to inflammatory signaling, while T-cell activity adds further mediator release. Keratinocytes then respond by producing chemokines that recruit leukocytes, illustrating how immune-cell communication and tissue-cell responses jointly shape cutaneous inflammation.
Characterization focuses on linked changes in the epidermis and immune compartment. Researchers examine epidermal thickening, altered keratinocyte differentiation, immune-cell infiltration, chemokine production, and inflammatory mediator activity. Assessing these features together can reveal whether skin-barrier disruption, cytokine signaling, leukocyte recruitment, or immune-mediated tissue injury is associated with the observed inflammatory pattern.
This model provides a framework for investigating skin barrier disruption, host–microbe interactions, cytokine signaling, and immune-mediated tissue injury. Its relevance to infection research comes from the opportunity to examine how inflammatory immune pathways affect the skin environment during host–microbe interactions. The same framework can also support evaluation of anti-inflammatory or immunomodulatory interventions.
Researchers can compare characterized inflammatory changes before and after an intervention, focusing on epidermal thickening, keratinocyte differentiation, immune-cell infiltration, and inflammatory signaling. A reduction in these linked features may indicate modulation of the inflammatory response. This approach supports assessment of anti-inflammatory or immunomodulatory strategies while preserving attention to the underlying tissue and immune mechanisms.
The combined presence of epidermal abnormalities, immune-cell infiltration, and cytokine-driven chemokine production can clarify how immune activation produces tissue effects. Linking these findings helps distinguish contributions from barrier disruption, keratinocyte responses, leukocyte recruitment, and dysregulated innate or adaptive pathways. Such characterization supports a more integrated interpretation of immune-mediated cutaneous injury.